slides · global inventory
Antagonist Introduction
Framework collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 1,369
Current window 811-840
Pages 46
Rows per page 30
Framework
811-840 of 1,369
98
The slide is a placeholder or transition slide for a specific point of contention in an activist deck.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
102
The slide uses expert quotes to discredit the company's technical claims.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
143
Uses expert quotes to frame the company's technology as a 'pipe dream' due to manufacturing challenges.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
145
Uses highlighted text within quotes to emphasize key criticisms.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
149
The slide uses a 'villain critique' style to undermine the technical feasibility of the company's core product.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
150
The slide uses expert testimony to undermine the company's technical feasibility claims.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technologyLoop · Cost Of Inaction1 hit
152
The slide uses a direct quote to undermine the technical viability of the company's core technology.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
155
Uses a quote from a former employee to validate the 'red flag' thesis.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
160
This is a transition or setup slide for a short-seller report.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
167
QuantumScape (QS)QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
168
Includes a screenshot of a tweet by Vinod Khosla and a quote from Barron's to illustrate the 'celebrity endorsement' and hype.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
170
Uses a 'villain' narrative technique to undermine investor credibility.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
172
Uses a quote from Steve LeVine (Quartz) and a photo of Obama with Sakti3 founder to establish credibility and highlight the 'hype' narrative.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
176
Uses a 'guilt by association' rhetorical strategy to cast doubt on the target company.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
184
The slide uses expert testimony to debunk the company's timeline and valuation.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
01
This is a classic activist short-seller cover page, utilizing aggressive, emotionally charged language to frame the thesis.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
11
The slide uses inflammatory language ('smelled a rat', 'drop like flies') to frame the company and investigator as negligent.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
18
The slide uses a Q&A format to build a case for the 'two-hit' hypothesis regarding drug interactions.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
19
The slide uses a combination of narrative description and citations of medical literature to establish the 'villain' (diazoxide) as dangerous.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
29
Uses patient testimonials as primary evidence to challenge the safety profile of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
37
The slide uses a 'villain' narrative by framing patient advocacy groups as manipulators of the regulatory process.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
62
The slide uses a 'nominee_bio' structure to present a 'villain_critique' or 'expose_contradiction' narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
82
The slide uses direct quotes to undermine the company's marketing claims and highlight physician concerns regarding side effects like diabetes.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
101
The slide uses direct quotes to expose contradictions in the drug's adoption and safety profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
162
The slide uses screenshots of Facebook posts to provide qualitative evidence of patient dissatisfaction and safety concerns.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
238
The slide uses direct quotes from an ex-employee to undermine the credibility of the company's clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
242
The slide uses direct quotes from a Key Opinion Leader (KOL) to build a case against the drug's safety and market viability.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
250
The slide uses direct quotes from a KOL to undermine the credibility of the clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
268
The slide uses a direct quote to highlight a conflict of interest or professional disagreement regarding medical standards.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
277
The slide uses a Q&A format to highlight negative expert sentiment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit